ch22 Flashcards
fungi
Most fungi exist as saprobes (absorbing
nutrients from dead organisms) and function as the major
decomposers of organic matter in the environment.
mycoses transmission
Mycoses are typically acquired via inhalation, trauma,
or ingestion; only very infrequently are fungi spread from person to prson.
mycoses transmission exception
One group of fungi that are contagious are dermatophytes, which live on the dead layers of skin and which
may be transmitted between people via fomites (inanimate objects).
Species of the genera Candida and Pneumocystis also appear to be transmitted at least some of
the time by contact among humans.
true fungal pathogens
Of all the fungi known to cause disease in humans, only four—
Blastomyces dermatitidis, Coccidioides immitis, Histoplasma capsulatum,
and Paracoccidioides brasiliensis—are considered true
pathogens; that is, they can cause disease in otherwise healthy
individuals.
opportunistic fungi
Other fungi, such as the common yeast, Candida
albicans (al´bi@kanz), are opportunistic fungi, which lack genes
for proteins that aid in colonizing body tissues, though they can
take advantage of some weakness in a host’s defenses to become
established and cause disease.
Four main factors increase an individual’s risk of experiencing
opportunistic mycoses:
invasive medical procedures, medical therapies, certain disease conditions, and specific lifestyle
factors
fungal pathogens and opportunists differ with
respect to geographical distribution:
Whereas the four pathogenic
fungi are endemic to certain regions, primarily in the Americas,
opportunistic fungi are distributed throughout the world.
dermatophytes
fungi that normally live on the skin,
nails, and hair—are the only fungi that do not fall comfortably
into either the pathogenic or the opportunistic grouping.
They are considered by some researchers to be “emerging”
pathogens. Dermatophytes can infect all individuals, not just
the immunocompromised, which makes them similar to the
pathogens. They are not, however, intrinsically invasive, being
limited to body surfaces. They also have a tendency to occur in
people with the same predisposing factors that allow access by
opportunistic fungi. For these reasons, dermatophytes will be
discussed as opportunists rather than as pathogens.
Fungal diseases are grouped into the following three categories
of clinical manifestations:
- fungal infections
- toxicoses
- allergies
fungal infections
the most common mycoses, are
caused by the presence in the body of either true pathogens
or opportunists.
toxicoses
Toxicoses (poisonings) are acquired through ingestion, as
occurs when poisonous mushrooms are eaten. rlatively rare
allergies
Allergies (hypersensitivity reactions) most commonly result
from the inhalation of fungal spores
Microbiologists culture fungi collected from patients on
Sabouraud dextrose agar, a medium that favors fungal growth
over bacterial growth
KOH preparations
Potassium hydroxide (KOH) preparations dissolve keratin in skin cells, leaving only fungal cells for examination
GMS stain
Gomori methenamine
silver (GMS) stain is used on tissue sections to stain fungal
cells, black (other cells remain unstained
direct immunofluorescence stain
used to detect fungal cells
in tissues; immunological tests are not always
useful for fungi
Diagnosis of opportunistic fungal infections is especially
challenging:
When a fungal opportunist infects tissues in which
it is normally not found, it may display abnormal morphology
that complicates identification.
- fungal masses resemble tumors
- symptoms andimaging profiles that resemble TB
Mycoses are among the most difficult diseases to heal for two
reasons.
First, fungi generally possess the biochemical ability to
resist T cells during cell-mediated immune responses. Second,
fungi are biochemically similar to human cells, which means
that most fungicides are toxic to human tissues.
The majority
of antifungal agents exploit one of the few differences between
human and fungal cells:
instead of cholesterol, the membranes
of fungal cells contain a related molecule, ergosterol. Antifungal
drugs target either ergosterol synthesis or its insertion into fungal
membranes. However, cholesterol and ergosterol are not
sufficiently different to prevent some damage to human tissues
by such antifungal agents
Serious side effects associated with
long-term use of almost all antifungal agents include
anemia,
headache, rashes, gastrointestinal upset, and serious liver and
kidney damage.
The “gold standard” of antifungal agents is
the fungicidal
drug amphotericin B, considered the best drug for treating systemic
mycoses and other fungal infections that do not respond
to other drugs. Unfortunately, it is also one of the more toxic
antifungal agents to humans.
azoles
Some major anti-ergosterol alternatives
to amphotericin B are the azole drugs—ketoconazole,
itraconazole, and fluconazole—which are fungistatic (inhibitory)
rather than fungicidal and less toxic to humans.
With just a few antifungal drugs being used for long periods
and treating more and more patients, scientists predict that the
drugs should select drug-resistant strains from the fungal population.
Fortunately, this is rarely the case; naturally occurring
resistance, especially against amphotericin B, is extremely rare,
though researchers cannot explain why resistance does not develop
as it does in bacterial populations under similar conditions
of long-term use.
Treatment of opportunistic fungal infections in immunocompromised
patients involves
two steps: a high-dose treatment
to eliminate or reduce the number of fungal pathogens, followed
by long-term (usually lifelong) maintenance therapy involving
the administration of antifungal agents to control ongoing infections
and prevent new infections.
Three antifungal drugs that do not target ergosterol are
griseofulvin, 5-fluorocytosine, and echinocandins
griseofulvin
interferes with microtubule formation and chromosomal
separation in mitosis. Griseofulvin accumulates in the outer epidermal layers of the skin, preventing fungal penetration
and growth. Since these skin cells are scheduled to die as they
move toward the surface, griseofulvin’s toxicity does not permanently
damage humans.
5-Fluorocytosine
a nucleoside analog that inhibits RNA
and DNA synthesis
echinocandins
inhibit the synthesis of 1,3-d-glucan, which is
a sugar that makes up part of the cell wall of a fungus. This
sugar does not occur in mammals
mycoses prevention
Prevention of fungal infections generally entails avoiding
endemic areas and keeping one’s immune system healthy.
Vaccines against fungi have been difficult to develop because
fungal metabolism is similar to our own.
systemic mycoses
Systemic mycoses—those fungal infections that spread
throughout the body—result from infections by one of the
four pathogenic fungi: Histoplama, Blastomyces, Coccidioides,
or Paracoccidioides. All are in the fungal division Ascomycota.
These pathogenic fungi are uniformly acquired through inhalation,
and all begin as a generalized pulmonary infection that
then spreads via the blood to the rest of the body. dimorphic
dimorphic
the four pathogenic fungi
- In the environment, where the temperature is
typically below 30°C, they appear as mycelial thalli composed
of hyphae, whereas within the body (37°C) they grow as spherical
yeasts
Yeast forms
invasive bc they express a variety of enzymes and other proteins that aid
their growth and reproduction in the body. For example, they
are tolerant of higher temperatures and are relatively resistant
to phagocytic killing
histoplasmosis organism
histoplasma capsulatum; an
ascomycete and the most common fungal pathogen affecting
humans.
histoplasma capsulatum env
found in moist soils containing high levels of
nitrogen, such as from the droppings of bats and birds. Spores
may become airborne and inhaled when soil containing the
fungus is disturbed by wind or by human activities.
h capsulatum in the body
H. capsulatum is an intracellular parasite that survives inhalation
and subsequent phagocytosis by macrophages in air
sacs of the lungs. These macrophages then disperse the fungus
beyond the lungs via the blood and lymph. Cell-mediated immunity eventually develops, clearing the organism from
healthy patients
histoplasma disease
- 95p asymptomatic
- 5p clinical: chronic pulmonary, chronic cutaneous, systemic, ocular histoplasmosis
chronic pulmonary histoplasmosis
characterized by severe
coughing, blood-tinged sputum, night sweats, loss
of appetite, and weight loss. It is often seen in individuals
with preexisting lung disease. It can be mistaken for
tuberculosis
chronic cutaneous histoplasmosis
characterized by ulcerative
skin lesions, can follow the spread of infection from the
lungs.
systemic histoplasmosis
can also follow if infection spreads
from the lungs, but it is usually seen only in AIDS patients.
This syndrome, characterized by enlargement of the spleen
and liver, can be rapid, severe, and fatal.
ocular histoplasmosis
a type I hypersensitivity reaction
against Histoplasma in the eye; it is characterized by inflammation
and redness.
histoplasmosis diagnosis
Diagnosis of histoplasmosis is based on the identification
of the distinctive budding yeast in KOH- or GMS-prepared
samples of skin scrapings, sputum, cerebrospinal fluid, or various
tissues. The diagnosis is confirmed by the observation of
dimorphism in cultures grown from such samples. Cultured
H. capsulatum produces distinctively spiny spores that are
also diagnostic
blastomycoses organism
caused by another ascomycete,
Blastomyces dermatitidis
Blastomyces dermatitidis env
B. dermatitidis normally
grows and sporulates in cool, damp soil rich in organic
material, such as decaying vegetation and animal wastes. In
humans, both recreational and occupational exposure occurs
when fungal spores in soil become airborne and are inhaled.
A relatively small inoculum can produce disease.
most common manifestation
of Blastomyces infection
Pulmonary blastomycosis is the most common manifestation
of Blastomyces infection. After spores enter the lungs,
they convert to yeast forms and multiply. Initial pulmonary
lesions are asymptomatic in most individuals. If symptoms
do develop, they are vague and include muscle aches,
cough, fever, chills, malaise, and weight loss. Purulent (pusfilled)
lesions develop and expand as the yeasts multiply,
resulting in death of tissues and cavity formation. In otherwise healthy people, pulmonary
blastomycosis typically resolves successfully, although
it may become chronic.
types of blastomycosis
pulmonary, cutaneous, osteoarticular
cutaneous blastomycosis
The fungus can spread beyond the lungs. Cutaneous blastomycosis
occurs in 60% to 70% of cases and consists of generally
painless lesions on the face and upper body (Figure 22.6). The
lesions can be raised and wartlike, or they may be craterlike if
tissue death occurs.
osteoarticular blastomycosis
In roughly 30% of cases, the fungus spreads
to the spine, pelvis, cranium, ribs, long bones, or subcutaneous
tissues surrounding joints, a condition called osteoarticular2
blastomycosis
Coccidioidomycosis organism
caused by
ascomycete Coccidioides immitis
c immitis cycle
In the warm and dry summer and fall months, particularly
in drought cycles, C. immitis grows as a mycelium and produces
sturdy chains of asexual spores called arthroconidia. When mature,
arthroconidia germinate into new mycelia in the environment,
but if inhaled, arthroconidia germinate in the lungs to produce
a parasitic form called a spherule. As each
spherule matures, it enlarges and generates a large number of
spores via multiple cleavages, until it ruptures and releases the
spores into the surrounding tissue. Each spore then forms a new spherule to continue the cycle of division and release. This type
of growth accounts for the seriousness of Coccidioides infection.
coccidioidomycosis symptoms
The major manifestation of coccidioidomycosis is pulmonary.
About 60% of patients experience either no symptoms or
mild, unremarkable symptoms that go unnoticed and typically resolve on their own. Other patients develop more severe infections
characterized by fever, cough, chest pain, difficulty breathing,
coughing up or spitting blood, headache, night sweats,
weight loss, and pneumonia; in some individuals a diffuse rash
may appear on the trunk.
- in those
who are severely immunocompromised, C. immitis spreads
from the lungs to various other sites. Invasion of the central
nervous system (CNS) may result in meningitis, headache,
nausea, and emotional disturbance. Infection can also spread
to the bones, joints, and painless subcutaneous tissues
paracoccidioidomycosis organism
Another ascomycete, Paracoccidioides brasiliensis
what is paracoccidioidomycosis
a chronic fungal disease similar to
blastomycosis and coccidioidomycosis.
- Because this fungus is far more
geographically limited than the other true fungal pathogens,
paracoccidioidomycosis is not a common disease.
paracoccidioidomycosis organism env
Paracoccidioides brasiliensis is found
in cool, damp soil
paracoccidioidomycosis symtptoms
Infections range from asymptomatic to systemic, and disease
first becomes apparent as a pulmonary form that is slow
to develop but manifests as chronic cough, fever, night sweats,
malaise, and weight loss. The fungus almost always spreads,
producing a chronic inflammatory disease of mucous membranes.
Painful ulcerated lesions of the gums, tongue, lips,
and palate progressively worsen over the course of weeks to
months
paracoccidioidomycosis diagnosis
KOH or GMS preparations of tissue samples reveal yeast
cells with multiple buds in a “steering wheel” formation that is
diagnostic for this organism
Opportunistic mycoses do not typically affect healthy humans
because
the fungi involved lack genes for virulence factors that
make them actively invasive.